Fig. 3
From: Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitis
Improvement in objective signs of vernal keratoconjunctivitis and blepharitis-related keratoconjunctivitis after initiation of CsA-CE treatment during the 3-, and the 6-month follow-up compared to baseline values. Graph showing mean ± SD improvement in visual analogue scale (VAS) score (0–5) for Bonini classification of hyperemic and swollen papillae on the tarsal surface of the eyelid in the VKC group (a), in the BKC group (b). Corneal fluorescein staining [CFS] on the modified Oxford scale in the VKC group (c), and in the BKC group (d). A decrease in VAS score from baseline indicates improvement. * indicates statistically significant (p < 0.05) improvement from baseline.
